IMVT fund manager activity
Immunovant, Inc · Nasdaq. Reported by 4 tracked fund managers in their 13F filings, Q3 2023 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| Joel Greenblatt - Gotham Asset Management | New | 30,100 | $1,159,753 | 0.00% | Aug 14, 2026 |
| David Einhorn - Greenlight Capital | No change | 93,520 | $3,603,325 | 0.09% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|---|---|---|---|---|
| David Einhorn - Greenlight Capital | New | 93,520 | $2,323,036 | 0.07% | May 15, 2026 |